UnitedHealth and 2 More Deep Value Stocks to Buy Before a Triple-Digit Rebound

Photo of Omor Ibne Ehsan
By Omor Ibne Ehsan Published

Key Points

  • These value stocks are trading at cheap prices compared to historical multiples.

  • Their underlying businesses are likely to recover in the long run.

  • As a result, they could deliver triple-digit gains.

  • It sounds nuts, but SoFi is giving new active invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for yourself (Sponsor)
    DISCLOSURE:
    INVESTMENTS ARE NOT FDIC INSURED • ARE NOT BANK GUARANTEED • MAY LOSE VALUE Brokerage and Active investing products offered through SoFi Securities LLC, member FINRA(www.finra.org)/SIPC(www.sipc.org). Advisory services are offered by SoFi Wealth LLC, an SEC-registered investment adviser. Information about SoFi Wealth’s advisory operations, services, and fees is set forth in SoFi Wealth’s current Form ADV Part 2 (Brochure), a copy of which is available upon request and at www.adviserinfo.sec.gov. Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 30 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Other fees, such as exchange fees, may apply. Please view our fee disclosure to view a full listing of fees. Investing in alternative investments and/or strategies may not be suitable for all investors and involves unique risks, including the risk of loss. An investor should consider their individual circumstances and any investment information, such as a prospectus, prior to investing. Interval Funds are illiquid instruments, the ability to trade on your timeline may be restricted. Brokerage and Active investing products offered through SoFi Securities LLC, Member FINRA(www.finra.org) /SIPC(www.sipc.org). There are limitations with fractional shares to consider before investing. During market hours fractional share orders are transmitted immediately in the order received. There may be system delays from receipt of your order until execution and market conditions may adversely impact execution prices. Outside of market hours orders are received on a not held basis and will be aggregated for each security then executed in the morning trade window of the next business day at market open. Share will be delivered at an average price received for executing the securities through a single batched order. Fractional shares may not be transferred to another firm. Fractional shares will be sold when a transfer or closure request is initiated. Please consider that selling securities is a taxable event. Options involve risks, including substantial risk of loss and the possibility an investor may lose the entire investment Before trading options please review the Characteristics and Risks of Standardized Options  Investing in an Initial Public Offering (IPO) involves substantial risk, including the risk of loss. Further, there are a variety of risk factors to consider when investing in an IPO, including but not limited to, unproven management, significant debt, and lack of operating history. For a comprehensive discussion of these risks please refer to SoFi Securities’ IPO Risk Disclosure Statement This should not be considered a recommendation to participate in IPOs and investors should carefully read the offering prospectus to determine whether an offering is consistent with their investment objectives, risk tolerance, and financial situation. New offerings generally have high demand and there are a limited number of shares available for distribution to participants. Many customers may not be allocated shares and share allocations may be significantly smaller than the shares requested in the customer’s initial offer (Indication of Interest). For more information on the allocation process please visit IPO Allocation.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
UnitedHealth and 2 More Deep Value Stocks to Buy Before a Triple-Digit Rebound

© Tero Vesalainen / Shutterstock.com

The stock market has gone through quite a serious recovery rally in the past few weeks. That rally has slowed down more recently, but investors who took the initiative when tariff fears were at their peaks are now laughing their way to the bank. Tech and growth stocks took the brunt of the bearishness, but these stocks have now bounced back by 20-30%, and even more if their businesses were sensitive to tariffs.

Now, tariffs have not only de-escalated, but a recent court order has put a halt to most of the tariffs. The government appealed and managed to get tariffs reinstated. That said, this is a temporary measure, and the government could start being less aggressive on tariffs going forward.

On top of that, recent macro figures have been quite good. Q1 GDP came in at -0.2% vs. -0.3% expected. It’s negative, but it’s nowhere as bad as many would have thought just a month and a half ago. With that in mind, here are some stocks that could recover as long as macros hold up:

UnitedHealth (UNH)

UnitedHealth (NYSE:UNH | UNH Price Prediction) is down over 50% from its April highs, and it looks more like a falling knife than value, even though the decline has slowed down. However, I think this could be a once-in-a-decade opportunity to buy the dip.

The biggest decline was from the Q1 2025 earnings disappointment and a full-year guidance cut. They mainly blamed high medical care utilization for that. Its Medicare Advantage business and issues within its Optum Health unit affected reimbursement due to member profile problems.

The CEO shortly resigned afterwards, and the full-year 2025 guidance was completely withdrawn. And right after that, reports came in that the Department of Justice was investigating this company. There are allegations that the company secretly paid nursing homes to minimize hospital transfers. Naturally, plenty of other lawsuits followed.

There are definitely risks here, but those seem mostly, if not fully priced in as shares trade at a 50% discount.

UNH now trades at just 12 times earnings, which is much lower than the historical median of 22 times earnings. If you take out non-recurring items, the earnings multiple drops down below 11 times.

UnitedHealth has grown its revenue by 12.7% annually in the past three years, and future revenue growth is expected at 8.6% annually this decade. On that note, it’s unlikely UNH will trade at such a discount for too long. One bad year shouldn’t hold down the linchpin of the healthcare insurance industry forever.

PDD Holdings (PDD)

PDD Holdings (NASDAQ:PDD) is the parent company of Pinduoduo in China and Temu in the West. Most of its revenue comes from China, but the company has underperformed recently due to the trade war and investment sentiment being against it. Many believe Temu was on the cusp of collapsing due to the Trump administration pulling away de minimis exemptions. However, the recent court order means Trump’s de minimis exemption is in question as well, since that suspension was through “emergency” powers from executive orders. Tariffs have been reinstated temporarily again, but they’re still hanging in the balance.

The most recent decline was due to PDD posting slowing growth and a falling bottom line due to a sharp rise in the cost of revenues and operating expenses, due to aggressive merchant support and marketing subsidies. The decline is expected to reverse in the coming years, and even with the recent bottom-line trends, the stock trades at just 8 times forward earnings.

It is expected to post 9.5% revenue growth for all of 2025 and 21.4% revenue growth next year, along with improving profitability. EPS growth (minus non-recurring items) is expected to be 16.2% annually this decade, and even if sentiment improves enough for Wall Street to pay 15 times trailing earnings for the stock, it could deliver triple-digit returns in the coming years.

The consensus price target of $144.55 implies 46.4% upside potential, but price targets go as high as $224 for the next 12 months.

Six Flags Entertainment (FUN)

Six Flags Entertainment (NYSE:FUN) is going through a post-merger integration with Cedar Fair. It hasn’t been fully smooth, and the combined company reported a $321 million operating loss in Q1. Both companies merged almost a year ago.

Since then, the stock is down 19%. If we zoom out further, Six Flags is down even more from its historical peaks.

FUN stock does not trade cheaply at current earnings multiples, but things could get significantly better as interest rates come down. In 2024, it posted a net loss of $206.7 million. However, EBITDA was $587 million. This loss was mainly due to $234.8 million in net interest expenses.

Even if we look at trailing-twelve-month data, EBITDA was $491 million vs. $293 million in net losses. As such, I see a significant recovery for FUN stock if interest rate cuts continue. Revenue hasn’t declined, and the company is expected to see over 10% revenue growth annually this decade.

It also comes with a dividend yield of 3.48%. The consensus price target of $49.2 implies 42.6% upside, though price targets go to $65.

Photo of Omor Ibne Ehsan
About the Author Omor Ibne Ehsan →

Omor Ibne Ehsan is a writer at 24/7 Wall St. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks.

Continue Reading

Top Gaining Stocks

F Vol: 216,261,152
ENPH Vol: 11,512,758
ON Vol: 21,618,191
AKAM Vol: 10,964,520
HPE Vol: 27,523,481

Top Losing Stocks

CTRA Vol: 73,319,495
FDS Vol: 1,153,303
CEG Vol: 6,653,829
J Vol: 2,649,092
PODD Vol: 1,990,609